vs

Side-by-side financial comparison of EyePoint, Inc. (EYPT) and VerifyMe, Inc. (VRME). Click either name above to swap in a different company.

EyePoint, Inc. is the larger business by last-quarter revenue ($5.3M vs $5.0M, roughly 1.1× VerifyMe, Inc.). VerifyMe, Inc. runs the higher net margin — -66.7% vs -1114.3%, a 1047.6% gap on every dollar of revenue. On growth, VerifyMe, Inc. posted the faster year-over-year revenue change (-7.4% vs -43.7%). Over the past eight quarters, VerifyMe, Inc.'s revenue compounded faster (-5.2% CAGR vs -40.8%).

EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.

VerifyMe, Inc. is a technology provider specializing in identity verification, anti-counterfeiting, and brand protection solutions. Its offerings include secure authentication tools, supply chain traceability systems, and customer engagement platforms, serving consumer goods, pharmaceutical, and retail sectors across North America and select global markets.

EYPT vs VRME — Head-to-Head

Bigger by revenue
EYPT
EYPT
1.1× larger
EYPT
$5.3M
$5.0M
VRME
Growing faster (revenue YoY)
VRME
VRME
+36.3% gap
VRME
-7.4%
-43.7%
EYPT
Higher net margin
VRME
VRME
1047.6% more per $
VRME
-66.7%
-1114.3%
EYPT
Faster 2-yr revenue CAGR
VRME
VRME
Annualised
VRME
-5.2%
-40.8%
EYPT

Income Statement — Q2 FY2025 vs Q3 FY2025

Metric
EYPT
EYPT
VRME
VRME
Revenue
$5.3M
$5.0M
Net Profit
$-59.4M
$-3.4M
Gross Margin
41.2%
Operating Margin
-1166.8%
-68.2%
Net Margin
-1114.3%
-66.7%
Revenue YoY
-43.7%
-7.4%
Net Profit YoY
-92.8%
-38.4%
EPS (diluted)
$-0.85
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EYPT
EYPT
VRME
VRME
Q3 25
$5.0M
Q2 25
$5.3M
$4.5M
Q1 25
$24.5M
$4.5M
Q4 24
$11.6M
Q3 24
$10.5M
$5.4M
Q2 24
$9.5M
$5.4M
Q1 24
$11.7M
$5.8M
Q4 23
$14.0M
$8.7M
Net Profit
EYPT
EYPT
VRME
VRME
Q3 25
$-3.4M
Q2 25
$-59.4M
$-291.0K
Q1 25
$-45.2M
$-571.0K
Q4 24
$-41.4M
Q3 24
$-29.4M
$-2.4M
Q2 24
$-30.8M
$-346.0K
Q1 24
$-29.3M
$-553.0K
Q4 23
$-14.1M
$2.0K
Gross Margin
EYPT
EYPT
VRME
VRME
Q3 25
41.2%
Q2 25
35.2%
Q1 25
33.4%
Q4 24
Q3 24
93.0%
34.9%
Q2 24
85.2%
39.1%
Q1 24
93.5%
39.2%
Q4 23
33.0%
Operating Margin
EYPT
EYPT
VRME
VRME
Q3 25
-68.2%
Q2 25
-1166.8%
-7.1%
Q1 25
-199.7%
-13.3%
Q4 24
-390.4%
Q3 24
-311.2%
-52.8%
Q2 24
-364.5%
-10.0%
Q1 24
-285.2%
-11.2%
Q4 23
-116.6%
0.8%
Net Margin
EYPT
EYPT
VRME
VRME
Q3 25
-66.7%
Q2 25
-1114.3%
-6.4%
Q1 25
-184.8%
-12.8%
Q4 24
-357.3%
Q3 24
-279.0%
-44.6%
Q2 24
-325.3%
-6.5%
Q1 24
-250.6%
-9.6%
Q4 23
-100.5%
0.0%
EPS (diluted)
EYPT
EYPT
VRME
VRME
Q3 25
$-0.26
Q2 25
$-0.85
$-0.02
Q1 25
$-0.65
$-0.05
Q4 24
$-0.65
Q3 24
$-0.54
$-0.23
Q2 24
$-0.58
$-0.03
Q1 24
$-0.55
$-0.05
Q4 23
$-0.32
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EYPT
EYPT
VRME
VRME
Cash + ST InvestmentsLiquidity on hand
$255.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$246.0M
$11.1M
Total Assets
$301.1M
$13.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EYPT
EYPT
VRME
VRME
Q3 25
Q2 25
$255.7M
Q1 25
$318.2M
Q4 24
$370.9M
Q3 24
$253.8M
$2.6M
Q2 24
$280.2M
$2.9M
Q1 24
$299.3M
$2.8M
Q4 23
$331.1M
$3.0M
Total Debt
EYPT
EYPT
VRME
VRME
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$500.0K
Q2 24
$600.0K
Q1 24
$800.0K
Q4 23
$875.0K
Stockholders' Equity
EYPT
EYPT
VRME
VRME
Q3 25
$11.1M
Q2 25
$246.0M
$14.4M
Q1 25
$298.4M
$14.6M
Q4 24
$336.5M
Q3 24
$218.7M
$10.3M
Q2 24
$228.3M
$12.3M
Q1 24
$249.9M
$12.4M
Q4 23
$266.3M
Total Assets
EYPT
EYPT
VRME
VRME
Q3 25
$13.3M
Q2 25
$301.1M
$17.2M
Q1 25
$362.6M
$17.1M
Q4 24
$418.5M
Q3 24
$300.9M
$14.8M
Q2 24
$324.2M
$17.5M
Q1 24
$329.2M
$17.9M
Q4 23
$355.2M
$20.7M
Debt / Equity
EYPT
EYPT
VRME
VRME
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.05×
Q2 24
0.05×
Q1 24
0.06×
Q4 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EYPT
EYPT
VRME
VRME
Operating Cash FlowLast quarter
$-62.6M
$243.0K
Free Cash FlowOCF − Capex
$-63.8M
FCF MarginFCF / Revenue
-1196.5%
Capex IntensityCapex / Revenue
22.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-194.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EYPT
EYPT
VRME
VRME
Q3 25
$243.0K
Q2 25
$-62.6M
$710.0K
Q1 25
$-53.1M
$-404.0K
Q4 24
$-35.8M
Q3 24
$-39.0M
$-10.0K
Q2 24
$-20.2M
$372.0K
Q1 24
$-31.2M
$-60.0K
Q4 23
$-23.1M
$843.0K
Free Cash Flow
EYPT
EYPT
VRME
VRME
Q3 25
Q2 25
$-63.8M
Q1 25
$-53.4M
Q4 24
$-36.2M
Q3 24
$-40.6M
$-12.0K
Q2 24
$-21.1M
$369.0K
Q1 24
$-32.4M
$-62.0K
Q4 23
$-24.0M
$840.0K
FCF Margin
EYPT
EYPT
VRME
VRME
Q3 25
Q2 25
-1196.5%
Q1 25
-218.4%
Q4 24
-312.7%
Q3 24
-385.8%
-0.2%
Q2 24
-222.4%
6.9%
Q1 24
-277.0%
-1.1%
Q4 23
-171.0%
9.6%
Capex Intensity
EYPT
EYPT
VRME
VRME
Q3 25
Q2 25
22.9%
Q1 25
1.1%
Q4 24
3.3%
Q3 24
15.0%
0.0%
Q2 24
9.5%
0.1%
Q1 24
10.2%
0.0%
Q4 23
6.3%
0.0%
Cash Conversion
EYPT
EYPT
VRME
VRME
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23
421.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EYPT
EYPT

Segment breakdown not available.

VRME
VRME

Proactive Services$4.2M83%
Other$869.0K17%

Related Comparisons